Ignacio Hormazábal-Aguayo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ignacio Hormazábal-Aguayo has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Antonio García-Hermoso
Navarrabiomed, Hospital Universitario de Navarra, Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain
7 shared publications - Yasmin Ezzatvar
Lifestyle Factors With Impact on Ageing and Overall Health (LAH) Research Group, Department of Nursing University of València Valencia Spain
7 shared publications - Jacinto Muñoz-Pardeza
Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain
6 shared publications - Nidia Huerta-Uribe
Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra 1 , Pamplona, Spain
5 shared publications - José Francisco López-Gil
School of Medicine, Universidad Espíritu Santo, Samborondón 092301, Ecuador
4 shared publications - Mikel Izquierdo
Navarrabiomed, Hospital Universitario de Navarra (HUN)‐Universidad Pública de Navarra (UPNA), IdiSNA Pamplona Spain
3 shared publications
Latest Publications
- Open Access
- 15 October 2025
- Published by Elsevier in Journal of Exercise Science & Fitness
- Vol. 23 (4) , 498-506
Sex-stratified compositional analysis of 24-h movement behaviors and their relationship with selective attention and cognitive flexibility in socioeconomically vulnerable children
- 15 October 2025
- Published by Elsevier in Journal of Exercise Science & Fitness
- Vol. 23 (4) , 498-506
Open AccessSex-stratified compositional analysis of 24-h movement behaviors and their relationship with selective attention and cognitive flexibility in socioeconomically vulnerable children
- 13 August 2025
- Published by American Diabetes Association in Diabetes Care
- Vol. 48 (10) , 1803-1811
Effect of Diactive-1 mHealth-Supported Progressive Resistance Training on Insulin Requirements, Glycemic Stability, and Muscular Strength in Children and Adolescents With Type 1 Diabetes: A Parallel-Group Randomized Controlled Trial
OBJECTIVE: To evaluate the effects of resistance training supported by the mobile health application Diactive-1 on the daily insulin dose and glycemic parameters in children and adolescents with type 1 diabetes. RESEARCH DESIGN AND METHODS: In this 24-week randomized clinical trial, Diactive-1 generated progressive overload resistance training sessions tailored to real-time glycemia and provided educational support. Insulin and glycemic parameters were collected from LibreView or CareLink, whereas glycosylated hemoglobin (HbA1c) was extracted from medical records. Muscular strength was assessed using a handgrip dynamometer and e-GYM machines, targeting pushing, pulling, and lower-limb movements. The effect was analyzed using linear mixed models. RESULTS: Sixty-two participants (age: 8–18 years, girls: 48%) with type 1 diabetes (HbA1c: 7.6% [60.4 mmol/mol]) were allocated to the usual care (n = 32) or the Diactive-1 group (n = 30). Daily insulin dose reductions were observed within the Diactive-1 group (mean difference [MD] −0.10 units/kg, 95% CI −0.18 to −0.01) and when compared with usual care (MD −0.17 units/kg, 95% CI −0.26 to −0.07). No adverse effects were observed on the glycemic risk index or the incidence of hypoglycemic events. Finally, handgrip strength (MD 2.90 kg, 95% CI 1.57–4.22), one-repetition maximum strength (MD 1.34, 95% CI 0.21–2.46), and muscular power (MD 0.97, 95% CI 0.01–1.93) increased. Four participants (6.5%) withdrew from the study. CONCLUSIONS: Diactive-1 appears to be a safe and feasible adjunct to standard care in children and adolescents with type 1 diabetes. Its resistance training component effectively reduced insulin requirements and improved muscular strength, without increasing the risk of adverse glycemic events.
- 13 August 2025
- Published by American Diabetes Association in Diabetes Care
- Vol. 48 (10) , 1803-1811
Effect of Diactive-1 mHealth-Supported Progressive Resistance Training on Insulin Requirements, Glycemic Stability, and Muscular Strength in Children and Adolescents With Type 1 Diabetes: A Parallel-Group Randomized Controlled Trial
OBJECTIVE: To evaluate the effects of resistance training supported by the mobile health application Diactive-1 on the daily insulin dose and glycemic parameters in children and adolescents with type 1 diabetes. RESEARCH DESIGN AND METHODS: In this 24-week randomized clinical trial, Diactive-1 generated progressive overload resistance training sessions tailored to real-time glycemia and provided educational support. Insulin and glycemic parameters were collected from LibreView or CareLink, whereas glycosylated hemoglobin (HbA1c) was extracted from medical records. Muscular strength was assessed using a handgrip dynamometer and e-GYM machines, targeting pushing, pulling, and lower-limb movements. The effect was analyzed using linear mixed models. RESULTS: Sixty-two participants (age: 8–18 years, girls: 48%) with type 1 diabetes (HbA1c: 7.6% [60.4 mmol/mol]) were allocated to the usual care (n = 32) or the Diactive-1 group (n = 30). Daily insulin dose reductions were observed within the Diactive-1 group (mean difference [MD] −0.10 units/kg, 95% CI −0.18 to −0.01) and when compared with usual care (MD −0.17 units/kg, 95% CI −0.26 to −0.07). No adverse effects were observed on the glycemic risk index or the incidence of hypoglycemic events. Finally, handgrip strength (MD 2.90 kg, 95% CI 1.57–4.22), one-repetition maximum strength (MD 1.34, 95% CI 0.21–2.46), and muscular power (MD 0.97, 95% CI 0.01–1.93) increased. Four participants (6.5%) withdrew from the study. CONCLUSIONS: Diactive-1 appears to be a safe and feasible adjunct to standard care in children and adolescents with type 1 diabetes. Its resistance training component effectively reduced insulin requirements and improved muscular strength, without increasing the risk of adverse glycemic events.
- Open Access
- 31 July 2025
- Published by Springer Nature in Diabetologia
- Vol. 68 (10) , 1-13
Compositional analysis of the association between 24 h movement behaviours, HbA1c and interstitial glucose in children and adolescents with type 1 diabetes mellitus: a two-year longitudinal analysis of the Diactive-1 cohort study
Aims/hypothesis: The aim of this study was to examine the association of physical activity, sedentarism and sleep with HbA1c and interstitial glucose in children and adolescents with type 1 diabetes through a 24 h compositional analysis. Methods: The study involved 83 young people diagnosed with type 1 diabetes (aged 6–18 years; 45% girls, mean HbA1c 57.54 ± 9.22 mmol/mol (7.4 ± 0.8%); median interstitial glucose 9.37 mmol/l [IQR 8.68–10.31]) from the Diactive-1 cohort study, followed up for 2 years. A triaxial accelerometer was used to objectively measure 24 h movement behaviours for 9 days. HbA1c levels were obtained from medical records, and interstitial glucose data were collected through continuous glucose monitoring. Linear mixed models were used to quantify associations between movement behaviours, interstitial glucose and HbA1c, maintaining the relative nature of the data based on the 24 h day. Results: A higher daily amount of sedentary behaviour, at the expense of sleep time, light or moderate-to-vigorous physical activity, was positively associated with HbA1c (unstandardised beta coefficient [B]=14.077 [95% CI 4.244, 23.956]; standardised beta coefficient [β]=0.368) and interstitial glucose (B=1.988; 95% CI 0.153, 3.880; β=0.261), while more sleep time, at the expense of sedentary behaviour, light or moderate-to-vigorous physical activity, was associated with a significant reduction in HbA1c (B=−12.712; 95% CI −25.204, −0.520; β=−0.197). Furthermore, reductions in both interstitial glucose (B=−1.580; 95% CI −2.800, −0.388; β=−0.283) and HbA1c (B=−9.361; 95% CI −15.856, −2.881; β=−0.330) were observed with increased daily time spent in moderate-to-vigorous physical activity at the expense of sedentary behaviour. Overall, the standardised beta coefficients indicated small to moderate effect sizes. Conclusions/interpretation: Our findings indicate that lower sedentary behaviour and more optimal sleep and physical activity patterns are associated with greater metabolic stability in children and adolescents with type 1 diabetes. These findings support the need for further research on balancing these behaviours for better diabetes management, and encourage adoption of a 24 h movement approach in clinical care. Graphical
- 31 July 2025
- Published by Springer Nature in Diabetologia
- Vol. 68 (10) , 1-13
Open AccessCompositional analysis of the association between 24 h movement behaviours, HbA1c and interstitial glucose in children and adolescents with type 1 diabetes mellitus: a two-year longitudinal analysis of the Diactive-1 cohort study
Aims/hypothesis: The aim of this study was to examine the association of physical activity, sedentarism and sleep with HbA1c and interstitial glucose in children and adolescents with type 1 diabetes through a 24 h compositional analysis. Methods: The study involved 83 young people diagnosed with type 1 diabetes (aged 6–18 years; 45% girls, mean HbA1c 57.54 ± 9.22 mmol/mol (7.4 ± 0.8%); median interstitial glucose 9.37 mmol/l [IQR 8.68–10.31]) from the Diactive-1 cohort study, followed up for 2 years. A triaxial accelerometer was used to objectively measure 24 h movement behaviours for 9 days. HbA1c levels were obtained from medical records, and interstitial glucose data were collected through continuous glucose monitoring. Linear mixed models were used to quantify associations between movement behaviours, interstitial glucose and HbA1c, maintaining the relative nature of the data based on the 24 h day. Results: A higher daily amount of sedentary behaviour, at the expense of sleep time, light or moderate-to-vigorous physical activity, was positively associated with HbA1c (unstandardised beta coefficient [B]=14.077 [95% CI 4.244, 23.956]; standardised beta coefficient [β]=0.368) and interstitial glucose (B=1.988; 95% CI 0.153, 3.880; β=0.261), while more sleep time, at the expense of sedentary behaviour, light or moderate-to-vigorous physical activity, was associated with a significant reduction in HbA1c (B=−12.712; 95% CI −25.204, −0.520; β=−0.197). Furthermore, reductions in both interstitial glucose (B=−1.580; 95% CI −2.800, −0.388; β=−0.283) and HbA1c (B=−9.361; 95% CI −15.856, −2.881; β=−0.330) were observed with increased daily time spent in moderate-to-vigorous physical activity at the expense of sedentary behaviour. Overall, the standardised beta coefficients indicated small to moderate effect sizes. Conclusions/interpretation: Our findings indicate that lower sedentary behaviour and more optimal sleep and physical activity patterns are associated with greater metabolic stability in children and adolescents with type 1 diabetes. These findings support the need for further research on balancing these behaviours for better diabetes management, and encourage adoption of a 24 h movement approach in clinical care. Graphical
- Open Access
- 5 June 2025
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (1) , e106-e115
The Role of Muscular Fitness on Bone Mineral Content and Areal Bone Mineral Density in Youth With Type 1 Diabetes
Context: Type 1 diabetes in youth increases the risk of compromised bone health due to glycemic dysregulation. Muscular fitness may play a role in improving bone health during growth. Objective: This study aimed to investigate the association between muscular fitness and bone health in youth with type 1 diabetes. Methods: A total of 83 young individuals with type 1 diabetes (aged 6-18 years; 44.6% girls) from the Diactive-1 cohort study were followed for 2 years. Dual-energy x-ray absorptiometry whole-body scans were used to assess bone mineral content (BMC) and areal bone mineral density (aBMD) of the total body less head (TBLH), arms, legs, pelvis, and spine. Muscular fitness (handgrip strength, 1 repetition maximum, and muscle power) was assessed with a dynamometer and eGYM devices. Handgrip strength and TBLH bone parameters were age- and sex-standardized using the FitBack Project and BMD Childhood Study, respectively. Results: Linear mixed models showed longitudinal associations of handgrip strength with TBLH-BMC (unstandardized beta coefficient [B] = 17.18, 95% confidence interval [CI] 12.47-21.90) and TBLH-aBMD (B = 0.004, 95% CI 0.002-0.006); RM with TBLH-BMC (B = 20.09, 95% CI 10.88-29.31) and TBLH-aBMD (B = 0.007, 95% CI 0.004-0.011); and power with TBLH-BMC (B = 26.80, 95% CI: 17.31-36.28) and TBLH-aBMD (B = 0.009, 95% CI 0.005-0.012). Comparable results were observed across the other regions (P < .05). Additionally, analyses with standardized data confirmed the relationships of handgrip z-scores with TBLH-BMC z-scores (B = 0.19, 95% CI 0.08-0.30) and TBLH-aBMD z-scores (B = 0.350, 95% CI: 0.210-0.490). Conclusion: In pediatric patients with type 1 diabetes, higher muscular fitness could serve as a complementary therapeutic strategy to preserve or enhance bone health.
- 5 June 2025
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (1) , e106-e115
Open AccessThe Role of Muscular Fitness on Bone Mineral Content and Areal Bone Mineral Density in Youth With Type 1 Diabetes
Context: Type 1 diabetes in youth increases the risk of compromised bone health due to glycemic dysregulation. Muscular fitness may play a role in improving bone health during growth. Objective: This study aimed to investigate the association between muscular fitness and bone health in youth with type 1 diabetes. Methods: A total of 83 young individuals with type 1 diabetes (aged 6-18 years; 44.6% girls) from the Diactive-1 cohort study were followed for 2 years. Dual-energy x-ray absorptiometry whole-body scans were used to assess bone mineral content (BMC) and areal bone mineral density (aBMD) of the total body less head (TBLH), arms, legs, pelvis, and spine. Muscular fitness (handgrip strength, 1 repetition maximum, and muscle power) was assessed with a dynamometer and eGYM devices. Handgrip strength and TBLH bone parameters were age- and sex-standardized using the FitBack Project and BMD Childhood Study, respectively. Results: Linear mixed models showed longitudinal associations of handgrip strength with TBLH-BMC (unstandardized beta coefficient [B] = 17.18, 95% confidence interval [CI] 12.47-21.90) and TBLH-aBMD (B = 0.004, 95% CI 0.002-0.006); RM with TBLH-BMC (B = 20.09, 95% CI 10.88-29.31) and TBLH-aBMD (B = 0.007, 95% CI 0.004-0.011); and power with TBLH-BMC (B = 26.80, 95% CI: 17.31-36.28) and TBLH-aBMD (B = 0.009, 95% CI 0.005-0.012). Comparable results were observed across the other regions (P < .05). Additionally, analyses with standardized data confirmed the relationships of handgrip z-scores with TBLH-BMC z-scores (B = 0.19, 95% CI 0.08-0.30) and TBLH-aBMD z-scores (B = 0.350, 95% CI: 0.210-0.490). Conclusion: In pediatric patients with type 1 diabetes, higher muscular fitness could serve as a complementary therapeutic strategy to preserve or enhance bone health.
- Open Access
- 29 May 2025
- Published by Universidad Publica de Navarra. Biblioteca
Impact of an mHealth and tailored physical activity intervention on the management and outcomes of children and adolescents with type 1 diabetes mellitus: a comprehensive approach to incidence, usability, and hypoglycemia risk
This doctoral thesis is grounded in a research project conducted by the "Child and Youth Physical Activity" unit at the Navarrabiomed Biomedical Research Centre. It includes data from both a longitudinal cohort study, known as the Diactive-1 Cohort Study, and a randomized controlled trial (RCT) titled Diactive-1: Comprehensive Management of Children and Adolescents with Type 1 Diabetes Mellitus (T1DM) through Personalized Physical Exercise and Glycaemic Control Using an eHealth System. This project was funded by the Carlos III Health Institute (PI_2020/140) and conducted in collaboration with the Paediatric Endocrinology Unit at the University Hospital of Navarra (HUN), Spain. The research aimed to understand the habits of paediatric patients with T1DM in Navarra and to propose a personalized, multidomain physical exercise program that includes carbohydrate counting and insulin therapy, with the goal of improving glycaemic control and treatment adherence through the use of a mobile application. This Doctoral Thesis consists of four studies published in international scientific journals. The first study (Chapter 1) aimed to determine the global incidence of T1DM in children and adolescents under 20 years old from the year 2000 to 2022, including a sub-analysis of the pre-pandemic and COVID-19 pandemic periods. The second study (Chapter 2) aimed to analyse the relationship between physical activity parameters, average glucose levels, and nocturnal hypoglycaemia events over 7 days, seeking to estimate an insulin dose threshold for preventing nocturnal hypoglycaemia events in children and adolescents with T1DM. The third study (Chapter 3) presents a study protocol for a RCT to compare the effects of a 24-week intervention using the Diactive-1 app versus standard care on insulin dose requirements in children and adolescents with T1DM. The secondary objectives include evaluating the impact of the Diactive-1 app intervention on glycaemic control, cardiometabolic profile, body composition, vascular function, physical condition, 24-hour movement behaviours, eating habits, and psychological well-being compared to a control group receiving standard care, over the 24-week intervention period. The fourth study (Chapter 4) focused on evaluating the usability of the Diactive-1 app, designed to support muscle-strengthening training in children and adolescents with T1DM, in line with the guidelines of the International Society for Paediatric and Adolescent Diabetes and the American Diabetes Association.
- 29 May 2025
- Published by Universidad Publica de Navarra. Biblioteca
Open AccessImpact of an mHealth and tailored physical activity intervention on the management and outcomes of children and adolescents with type 1 diabetes mellitus: a comprehensive approach to incidence, usability, and hypoglycemia risk
This doctoral thesis is grounded in a research project conducted by the "Child and Youth Physical Activity" unit at the Navarrabiomed Biomedical Research Centre. It includes data from both a longitudinal cohort study, known as the Diactive-1 Cohort Study, and a randomized controlled trial (RCT) titled Diactive-1: Comprehensive Management of Children and Adolescents with Type 1 Diabetes Mellitus (T1DM) through Personalized Physical Exercise and Glycaemic Control Using an eHealth System. This project was funded by the Carlos III Health Institute (PI_2020/140) and conducted in collaboration with the Paediatric Endocrinology Unit at the University Hospital of Navarra (HUN), Spain. The research aimed to understand the habits of paediatric patients with T1DM in Navarra and to propose a personalized, multidomain physical exercise program that includes carbohydrate counting and insulin therapy, with the goal of improving glycaemic control and treatment adherence through the use of a mobile application. This Doctoral Thesis consists of four studies published in international scientific journals. The first study (Chapter 1) aimed to determine the global incidence of T1DM in children and adolescents under 20 years old from the year 2000 to 2022, including a sub-analysis of the pre-pandemic and COVID-19 pandemic periods. The second study (Chapter 2) aimed to analyse the relationship between physical activity parameters, average glucose levels, and nocturnal hypoglycaemia events over 7 days, seeking to estimate an insulin dose threshold for preventing nocturnal hypoglycaemia events in children and adolescents with T1DM. The third study (Chapter 3) presents a study protocol for a RCT to compare the effects of a 24-week intervention using the Diactive-1 app versus standard care on insulin dose requirements in children and adolescents with T1DM. The secondary objectives include evaluating the impact of the Diactive-1 app intervention on glycaemic control, cardiometabolic profile, body composition, vascular function, physical condition, 24-hour movement behaviours, eating habits, and psychological well-being compared to a control group receiving standard care, over the 24-week intervention period. The fourth study (Chapter 4) focused on evaluating the usability of the Diactive-1 app, designed to support muscle-strengthening training in children and adolescents with T1DM, in line with the guidelines of the International Society for Paediatric and Adolescent Diabetes and the American Diabetes Association.
- Open Access
- 5 March 2025
- Published by Wiley in Scandinavian Journal of Medicine & Science in Sports
- Vol. 35 (3) , e70033
Physical Fitness and Activity Levels as Predictors of Subjective Well‐Being in Youths With Type 1 Diabetes Mellitus: A 2‐Year Longitudinal Analysis of the Diactive‐1 Cohort Study
Subjective well‐being (SWB), including cognitive and affective components, may be influenced by the management of type 1 diabetes mellitus (T1DM). Physical fitness and adherence to physical activity (PA) are associated with better glycaemic stability and diabetes management. However, the relationship with SWB is not yet understood. The aim of the study was to determine the relationship between physical fitness, PA, and SWB over two years in youths with T1DM. This longitudinal study involved 83 participants (aged 6–18 years; 44.6% girls) from the Diactive‐1 Cohort. Physical fitness was assessed by spirometry (peak oxygen consumption) and dynamometry (handgrip strength). PA domains were measured using triaxial accelerometers, whereas the number of days participating in muscle‐strengthening activities was assessed using a question. The Cuestionario Único de Bienestar Escolar was used to determine SWB. Glycaemic stability was determined when glycosylated hemoglobin < 7%, coefficient of variability ≤ 36%, and time‐in‐range target > 70% were met. The linear mixed models used considered three assessments and subject variability, showing significant associations between overall physical fitness (unstandardized beta coefficient [B] = 1.778, 95% confidence interval [CI] 0.413–3.158; p = 0.012) and total PA (B = 0.034, 95% CI 0.005–0.063; p = 0.020) with SWB. Although time did not moderate the association with physical fitness (p = 0.116), this was true for PA only in the second year (p = 0.020). In contrast, glycaemic stability did not moderate the associations (p > 0.05). In conclusion, physical fitness and PA are associated with greater SWB in young people with T1DM, which may play a role in the psychological aspects of disease management.
- 5 March 2025
- Published by Wiley in Scandinavian Journal of Medicine & Science in Sports
- Vol. 35 (3) , e70033
Open AccessPhysical Fitness and Activity Levels as Predictors of Subjective Well‐Being in Youths With Type 1 Diabetes Mellitus: A 2‐Year Longitudinal Analysis of the Diactive‐1 Cohort Study
Subjective well‐being (SWB), including cognitive and affective components, may be influenced by the management of type 1 diabetes mellitus (T1DM). Physical fitness and adherence to physical activity (PA) are associated with better glycaemic stability and diabetes management. However, the relationship with SWB is not yet understood. The aim of the study was to determine the relationship between physical fitness, PA, and SWB over two years in youths with T1DM. This longitudinal study involved 83 participants (aged 6–18 years; 44.6% girls) from the Diactive‐1 Cohort. Physical fitness was assessed by spirometry (peak oxygen consumption) and dynamometry (handgrip strength). PA domains were measured using triaxial accelerometers, whereas the number of days participating in muscle‐strengthening activities was assessed using a question. The Cuestionario Único de Bienestar Escolar was used to determine SWB. Glycaemic stability was determined when glycosylated hemoglobin < 7%, coefficient of variability ≤ 36%, and time‐in‐range target > 70% were met. The linear mixed models used considered three assessments and subject variability, showing significant associations between overall physical fitness (unstandardized beta coefficient [B] = 1.778, 95% confidence interval [CI] 0.413–3.158; p = 0.012) and total PA (B = 0.034, 95% CI 0.005–0.063; p = 0.020) with SWB. Although time did not moderate the association with physical fitness (p = 0.116), this was true for PA only in the second year (p = 0.020). In contrast, glycaemic stability did not moderate the associations (p > 0.05). In conclusion, physical fitness and PA are associated with greater SWB in young people with T1DM, which may play a role in the psychological aspects of disease management.
- Open Access
- 1 January 2025
- Published by Wiley in Pediatric Diabetes
- Vol. 2025 (1)
Global Prevalence of Microvascular Complications in Children and Adolescents With Type 1 and Type 2 Diabetes: A Systematic Review and Meta‐Analysis
Aim: To quantify the prevalence of microvascular complications of children and adolescents with type 1 and type 2 diabetes by performing a meta‐analysis of observational studies. Methods: A systematic search in PubMed, EMBASE, and Web of Science was performed from 2000 to August 2025. Studies that reported the prevalence of microvascular complications in children and adolescents with diabetes were included. Study characteristics and prevalence estimates were extracted from each study. Pooled prevalence rates for microvascular complications were calculated using a random‐effects model with Freeman‐Tukey double arcsine transformation to stabilize variance. Results: A total of 57 studies were included, comprising 51,819 children and adolescents diagnosed with diabetes (type 1: n = 44,150 and type 2: n = 7,669), with a mean age of 14.5 and 15.2 years old, respectively. Pooled prevalence of complications in youth with type 1 vs. type 2 diabetes was 22.07% (95% CI: 16.86–27.75) vs. 11.04% (95% CI: 2.73–23.45) for peripheral neuropathy, 31.98% (95% CI: 11.13–57.44) vs. 15.37% (95% CI: 3.09–34.29) for autonomic neuropathy, 13.76% (95% CI: 6.43–23.24) vs. 2.97% (95% CI: 0.00–10.33) for retinopathy, and 13.70% (95% CI: 10.25–17.54) vs. 12.63% (95% CI: 7.99–18.07) for nephropathy, with high heterogeneity across studies and no significant differences between diabetes types. Meta‐regression analyses showed no significant associations between complication prevalence and HbA1c, diabetes duration, lipid levels, cohort year, or age. Conclusions/Interpretation: Microvascular complications affect at least one in 10 youths with diabetes before age 20, with similar prevalence in type 1 and type 2 diabetes. Given the high rates and early onset, routine screening and early intervention are essential for all young people with diabetes to prevent or limit progression of vascular damage, regardless of diabetes type, glycemic stability, or disease duration.
- 1 January 2025
- Published by Wiley in Pediatric Diabetes
- Vol. 2025 (1)
Open AccessGlobal Prevalence of Microvascular Complications in Children and Adolescents With Type 1 and Type 2 Diabetes: A Systematic Review and Meta‐Analysis
Aim: To quantify the prevalence of microvascular complications of children and adolescents with type 1 and type 2 diabetes by performing a meta‐analysis of observational studies. Methods: A systematic search in PubMed, EMBASE, and Web of Science was performed from 2000 to August 2025. Studies that reported the prevalence of microvascular complications in children and adolescents with diabetes were included. Study characteristics and prevalence estimates were extracted from each study. Pooled prevalence rates for microvascular complications were calculated using a random‐effects model with Freeman‐Tukey double arcsine transformation to stabilize variance. Results: A total of 57 studies were included, comprising 51,819 children and adolescents diagnosed with diabetes (type 1: n = 44,150 and type 2: n = 7,669), with a mean age of 14.5 and 15.2 years old, respectively. Pooled prevalence of complications in youth with type 1 vs. type 2 diabetes was 22.07% (95% CI: 16.86–27.75) vs. 11.04% (95% CI: 2.73–23.45) for peripheral neuropathy, 31.98% (95% CI: 11.13–57.44) vs. 15.37% (95% CI: 3.09–34.29) for autonomic neuropathy, 13.76% (95% CI: 6.43–23.24) vs. 2.97% (95% CI: 0.00–10.33) for retinopathy, and 13.70% (95% CI: 10.25–17.54) vs. 12.63% (95% CI: 7.99–18.07) for nephropathy, with high heterogeneity across studies and no significant differences between diabetes types. Meta‐regression analyses showed no significant associations between complication prevalence and HbA1c, diabetes duration, lipid levels, cohort year, or age. Conclusions/Interpretation: Microvascular complications affect at least one in 10 youths with diabetes before age 20, with similar prevalence in type 1 and type 2 diabetes. Given the high rates and early onset, routine screening and early intervention are essential for all young people with diabetes to prevent or limit progression of vascular damage, regardless of diabetes type, glycemic stability, or disease duration.
- Open Access
- 1 December 2023
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 40 (3) , e3749
Incidence of type 1 diabetes mellitus in children and adolescents under 20 years of age across 55 countries from 2000 to 2022: A systematic review with meta‐analysis
Aims: The aim of this study was to determine the global incidence of type 1 diabetes mellitus (T1DM) in children and adolescents under 20 years of age from 2000 to 2022.Materials and Methods: Two reviewers searched three electronic databases (PubMed, Web of Science, and CINAHL) for studies published between January 2000 and November 2022. Pooled estimates of T1DM incidence with a 95% confidence interval (CI) per 100,000 person‐years were calculated by country/region, sex, age, and COVID‐19 pandemic period (pre‐COVID‐19 and pandemic).Results: The study included 126 studies from 55 countries and 18 regions. The incidence rate (IR) of T1DM from 2000 to 2022 was 14.07 (95%CI, 12.15–16.29) per 100,000 person‐years. Finland and high‐income North America had the highest IR, with 56.81 (95%CI, 55.91–57.73) and 28.77 (95%CI, 26.59–31.13) per 100,000 person‐years, respectively. The IR was 13.37 (95%CI, 10.60–16.88) per 100,000 person‐years in boys and 13.87 (95%CI, 11.51–16.70) per 100,000 person‐years in girls. There were statistically significant differences among different age ranges: 0–4 versus 5–9 and 10–14 years old (p < 0.001); 5–9 versus 15–19 (p < 0.001) and 10–14 versus 15–19 years old (p = 0.003). Finally, during the pandemic period (2020–2022), the IR was 24.84 (95%CI, 17.16–35.96) per 100,000 person‐years, which was higher but not significant compared with the prepandemic period (2017–2019) of 13.56 (95%CI, 7.49–24.56) per 100,000 person‐years (p = 0.090).Conclusions: The IR of T1DM in children and adolescents under 20 years of age is substantial, especially during the pandemic period, although it varies across regions. More reliable data from additional countries are needed to determine the worldwide incidence of T1DM.
- 1 December 2023
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 40 (3) , e3749
Open AccessIncidence of type 1 diabetes mellitus in children and adolescents under 20 years of age across 55 countries from 2000 to 2022: A systematic review with meta‐analysis
Aims: The aim of this study was to determine the global incidence of type 1 diabetes mellitus (T1DM) in children and adolescents under 20 years of age from 2000 to 2022.Materials and Methods: Two reviewers searched three electronic databases (PubMed, Web of Science, and CINAHL) for studies published between January 2000 and November 2022. Pooled estimates of T1DM incidence with a 95% confidence interval (CI) per 100,000 person‐years were calculated by country/region, sex, age, and COVID‐19 pandemic period (pre‐COVID‐19 and pandemic).Results: The study included 126 studies from 55 countries and 18 regions. The incidence rate (IR) of T1DM from 2000 to 2022 was 14.07 (95%CI, 12.15–16.29) per 100,000 person‐years. Finland and high‐income North America had the highest IR, with 56.81 (95%CI, 55.91–57.73) and 28.77 (95%CI, 26.59–31.13) per 100,000 person‐years, respectively. The IR was 13.37 (95%CI, 10.60–16.88) per 100,000 person‐years in boys and 13.87 (95%CI, 11.51–16.70) per 100,000 person‐years in girls. There were statistically significant differences among different age ranges: 0–4 versus 5–9 and 10–14 years old (p < 0.001); 5–9 versus 15–19 (p < 0.001) and 10–14 versus 15–19 years old (p = 0.003). Finally, during the pandemic period (2020–2022), the IR was 24.84 (95%CI, 17.16–35.96) per 100,000 person‐years, which was higher but not significant compared with the prepandemic period (2017–2019) of 13.56 (95%CI, 7.49–24.56) per 100,000 person‐years (p = 0.090).Conclusions: The IR of T1DM in children and adolescents under 20 years of age is substantial, especially during the pandemic period, although it varies across regions. More reliable data from additional countries are needed to determine the worldwide incidence of T1DM.